A preliminary investigation on the relationship between gut microbiota and gene expressions in peripheral mononuclear cells of infants with autism spectrum disorders

References

• Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383:896–910.10.1016/S0140-6736(13)61539-1
   PubMed Web of Science ®Google Scholar
• Dietert RR, Dietert JM, Dewitt JC. Environmental risk factors for autism. Emerg. Health Threats J. 2011;4:7111.
   PubMedGoogle Scholar
• Jeste SS, Geschwind DH. Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nat. Rev. Neurol. 2014;10:74–81.10.1038/nrneurol.2013.278
   PubMed Web of Science ®Google Scholar
• Lee WJ, Hase K. Gut microbiota-generated metabolites in animal health and disease. Nat. Chem. Biol. 2014;10:416–424.10.1038/nchembio.1535
   PubMed Web of Science ®Google Scholar
• Adams JB, Johansen LJ, Powell LD, et al. Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;11:22.10.1186/1471-230X-11-22
   PubMed Web of Science ®Google Scholar
• Finegold SM, Dowd SE, Gontcharova V, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010;16:444–453.10.1016/j.anaerobe.2010.06.008
   PubMed Web of Science ®Google Scholar
• Finegold SM, Molitoris D, Song Y, et al. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 2002;35:S6–S16.10.1086/cid.2002.35.issue-s1
   PubMed Web of Science ®Google Scholar
• Parracho HM, Bingham MO, Gibson GR, et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 2005;54:987–991.10.1099/jmm.0.46101-0
   PubMed Web of Science ®Google Scholar
• Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl. Environ. Microbiol. 2004;70:6459–6465.10.1128/AEM.70.11.6459-6465.2004
   PubMed Web of Science ®Google Scholar
• Wang L, Christophersen CT, Sorich MJ, et al. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl. Environ. Microbiol. 2011;77:6718–6721.10.1128/AEM.05212-11
   PubMed Web of Science ®Google Scholar
• Williams BL, Hornig M, Buie T, et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One. 2011;6:e24585.10.1371/journal.pone.0024585
   PubMed Web of Science ®Google Scholar
• Williams BL, Hornig M, Parekh T, et al. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio. 2012;3:e00261-1–e00261-11.
   Google Scholar
• Kau AL, Ahern PP, Griffin NW, et al. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474:327–336.10.1038/nature10213
   PubMed Web of Science ®Google Scholar
• Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136:2003–2014.10.1053/j.gastro.2009.01.075
   PubMed Web of Science ®Google Scholar
• Neufeld KM, Kang N, Bienenstock J, et al. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motil. 2011;23:255–264, e119.
   PubMed Web of Science ®Google Scholar
• Louis P. Does the human gut microbiota contribute to the etiology of autism spectrum disorders? Dig. Dis. Sci. 2012;57:1987–1989.10.1007/s10620-012-2286-1
   PubMed Web of Science ®Google Scholar
• De Angelis M, Piccolo M, Vannini L, et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013;8:e76993.10.1371/journal.pone.0076993
   PubMed Web of Science ®Google Scholar
• Kang DW, Park JG, Ilhan ZE, et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One. 2013;8:e68322.10.1371/journal.pone.0068322
   PubMed Web of Science ®Google Scholar
• Kamio Y, Yukihiro R, Adachi J, et al. Reliability and validity of the pervasive developmental disorder (PDD)-Autism society Japan rating scale (PARS): a behavior checklist for adolescents and adults with PDDs. Clin. Psychiat. (Seishin-Igaku). 2006;48:495–505.
   Google Scholar
• Robins DL, Fein D, Barton ML, et al. The modified checklist for autism in toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J. Autism Dev. Disord. 2001;31:131–144.10.1023/A:1010738829569
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Inoue R, Tsuruta T, et al. Long-term oral administration of cows’ milk improves insulin sensitivity in rats fed a high-sucrose diet. Br. J. Nutr. 2009;102:1324–1333.10.1017/S0007114509990365
   PubMed Web of Science ®Google Scholar
• Fadrosh DW, Ma B, Gajer P, et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome. 2014;2:6.10.1186/2049-2618-2-6
   PubMed Web of Science ®Google Scholar
• Magoc T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27:2957–2963.10.1093/bioinformatics/btr507
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods. 2010;7:335–336.10.1038/nmeth.f.303
   PubMed Web of Science ®Google Scholar
• Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460–2461.10.1093/bioinformatics/btq461
   PubMed Web of Science ®Google Scholar
• Edgar RC, Haas BJ, Clemente JC, et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011;27:2194–2200.10.1093/bioinformatics/btr381
   PubMed Web of Science ®Google Scholar
• Wang Q, Garrity GM, Tiedje JM, et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007;73:5261–5267.10.1128/AEM.00062-07
   PubMed Web of Science ®Google Scholar
• Nishibayashi R, Inoue R, Harada Y, et al. RNA of Enterococcus faecalis strain EC-12 is a major component inducing interleukin-12 production from human monocytic cells. PLoS One. 2015;10:e0129806.10.1371/journal.pone.0129806
   Google Scholar
• Ogawa S, Okutani M, Tsukahara T, et al. Comparison of gene expression profiles of T cells in porcine colostrum and peripheral blood. Am. J. Vet. Res. Forthcoming.
   Google Scholar
• Yoshikawa T, Inoue R, Matsumoto M, et al. Comparative expression of hexose transporters (SGLT1, GLUT1, GLUT2 and GLUT5) throughout the mouse gastrointestinal tract. Histochem. Cell Biol. 2011;135:183–194.10.1007/s00418-011-0779-1
   PubMed Web of Science ®Google Scholar
• Singh VK. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J. Neuroimmunol. 1996;66:143–145.
   PubMed Web of Science ®Google Scholar
• Stubbs G. Interferonemia and autism. J. Autism Dev. Disord. 1995;25:71–73.10.1007/BF02178169
   PubMed Web of Science ®Google Scholar
• Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005;57:67–81.10.1002/(ISSN)1531-8249
   PubMed Web of Science ®Google Scholar
• Paakki JJ, Rahko J, Long X, et al. Alterations in regional homogeneity of resting-state brain activity in autism spectrum disorders. Brain Res. 2010;1321:169–179.10.1016/j.brainres.2009.12.081
   PubMed Web of Science ®Google Scholar
• Estes ML, McAllister AK. Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat. Rev. Neurosci. 2015;16:469–486.10.1038/nrn3978
   PubMed Web of Science ®Google Scholar
• Bell JG, MacKinlay EE, Dick JR, et al. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot. Essent. Fatty Acids. 2004;71:201–204.10.1016/j.plefa.2004.03.008
   PubMed Web of Science ®Google Scholar
• Shon SP, Ja DA. Ethnicity and family therapy. In: McGoldrick M, Pearce JK, and Giordano J, editors. New York, NY: The Guilford Press; 1982. p. 208–228.
   Google Scholar
• Braun KL, Browne CV. Perceptions of dementia, caregiving, and help seeking among Asian and Pacific Islander Americans. Health Soc. Work. 1998;23:262–274.10.1093/hsw/23.4.262
   PubMed Web of Science ®Google Scholar
• Duncan SH, Hold GL, Harmsen HJ, et al. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 2002;52:2141–2146.
   PubMed Web of Science ®Google Scholar
• Miquel S, Martin R, Rossi O, et al. Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 2013;16:255–261.10.1016/j.mib.2013.06.003
   PubMed Web of Science ®Google Scholar
• Quévrain E, Maubert MA, Michon C, et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease. Gut. 2016;65:415–425.10.1136/gutjnl-2014-307649
   PubMed Web of Science ®Google Scholar
• Quévrain E, Maubert M-A, Sokol H, et al. The presence of the anti-inflammatory protein MAM, from Faecalibacterium prausnitzii, in the intestinal ecosystem. Gut. 2016;65:882.
   PubMed Web of Science ®Google Scholar
• Hansen R, Russell RK, Reiff C, et al. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn’s but not in ulcerative colitis. Am. J. Gastroenterol. 2012;107:1913–1922.10.1038/ajg.2012.335
   PubMed Web of Science ®Google Scholar
• Balamurugan R, George G, Kabeerdoss J, et al. Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br. J. Nutr. 2010;103:335–338.10.1017/S0007114509992182
   PubMed Web of Science ®Google Scholar
• de La Serre CB, Ellis CL, Lee J, et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010;299:G440–G448.10.1152/ajpgi.00098.2010
   PubMed Web of Science ®Google Scholar
• Song H, Yoo Y, Hwang J, et al. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J. Allergy Clin. Immunol. 2015;137:852–860.
   PubMed Web of Science ®Google Scholar
• Hsiao EY, McBride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155:1451–1463.10.1016/j.cell.2013.11.024
   PubMed Web of Science ®Google Scholar
• Liu C, Finegold SM, Song Y, et al. Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov., Blautia producta comb. nov., Blautia schinkii comb. nov. and description of Blautia wexlerae sp. nov., isolated from human faeces. Int. J. Syst. Evol. Microbiol. 2008;58:1896–1902.10.1099/ijs.0.65208-0
   PubMed Web of Science ®Google Scholar
• Schreck KA, Williams K, Smith AF. A comparison of eating behaviors between children with and without autism. J. Autism Dev. Disord. 2004;34:433–438.10.1023/B:JADD.0000037419.78531.86
   PubMed Web of Science ®Google Scholar
• Ashwood P, Krakowiak P, Hertz-Picciotto I, et al. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011;25:40–45.10.1016/j.bbi.2010.08.003
   PubMed Web of Science ®Google Scholar
• Suzuki K, Matsuzaki H, Iwata K, et al. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One. 2011;6:e20470.10.1371/journal.pone.0020470
   PubMed Web of Science ®Google Scholar
• Hill NO, Pardue A, Kahn A, et al. Phase 1 human leukocyte interferon trials in cancer and leukemia. J. Clin. Hematol. Oncol. 1981;11:23–35.
   Google Scholar
• Finsen B, Owens T. Innate immune responses in central nervous system inflammation. FEBS Lett. 2011;585:3806–3812.10.1016/j.febslet.2011.05.030
   PubMed Web of Science ®Google Scholar
• Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 2005;5:375–386.10.1038/nri1604
   PubMed Web of Science ®Google Scholar
• Müller A, Oertli M, Arnold IC. H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection. Cell Commun. Signal. 2011;9:25.10.1186/1478-811X-9-25
   PubMed Web of Science ®Google Scholar
• Takayanagi H. All interferons are not equal: specific mechanisms of interfering with osteoclastogenesis. Bonekey Osteovision. 2005;2:24–28.10.1138/20050183
   Google Scholar
• Mehla R, Guha D, Ayyavoo V. Chemokine deregulation in HIV infection: role of interferon gamma induced Th1-chemokine signaling. J. Clin. Cell Immunol. 2012;S7:4.
   Google Scholar
• Lepej SŽ, Mišić-Majerus L, Jeren T, et al. Chemokines CXCL10 and CXCL11 in the cerebrospinal fluid of patients with tick-borne encephalitis. Acta Neurol. Scand. 2007;115:109–114.10.1111/ane.2007.115.issue-2
   PubMed Web of Science ®Google Scholar
• Moniuszko A, Czupryna P, Pancewicz S, et al. Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis. Immunol. Lett. 2014;157:45–50.10.1016/j.imlet.2013.11.002
   PubMed Web of Science ®Google Scholar
• Müller M, Carter S, Hofer MJ, et al. Review: the chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity – a tale of conflict and conundrum. Neuropathol. Appl. Neurobiol. 2010;36:368–387.10.1111/nan.2010.36.issue-5
   PubMed Web of Science ®Google Scholar
• Ashwood P, Wills S, Van de Water J. The immune response in autism: a new frontier for autism research. J. Leukoc. Biol. 2006;80:1–15.
   PubMed Web of Science ®Google Scholar
• Akbar AN, Lord JM, Salmon M. IFN-α and IFN-β: a link between immune memory and chronic inflammation. Immunol. Today. 2000;21:337–342.10.1016/S0167-5699(00)01652-2
   PubMedGoogle Scholar
• Lee PY, Li Y, Kumagai Y, et al. Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am. J. Pathol. 2009;175:2023–2033.10.2353/ajpath.2009.090328
   PubMed Web of Science ®Google Scholar
• de Theije CG, Wu J, da Silva SL, et al. Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management. Eur. J. Pharmacol. 2011;668(Suppl 1):S70–S80.10.1016/j.ejphar.2011.07.013
   PubMed Web of Science ®Google Scholar
• Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55:1512–1520.
   Google Scholar